“…Quinazolinone derivatives have been proven to exhibit interesting medicinal and therapeutical activities, including antitumor, antihypertensive, antifungal, analgesic and anti-inflammatory, antibacterial, antihistaminic, anticancer, antioxidant, and anti-HIV activities ( Karan et al, 2021 ). To the best of our knowledge, a few reports are available for the preparation of triazoloquinazolinones by condensation of 3,5-diamino-1,2,4-triazole, aromatic aldehydes, and dimedone ( Lipson et al, 2003 ; Heravi et al, 2008 ; Heravi et al, 2010 ; Krishnamurthy and Jagannath, 2013 ; Puligoundla et al, 2013 ; Mousavi and Maghsoodlou, 2015 ) such as H 6 P 2 W 18 O 62 •18H 2 O ( Heravi et al, 2008 ), microwave ( Krishnamurthy and Jagannath, 2013 ), molecular iodine (I 2 ) ( Puligoundla et al, 2013 ), refluxing in DMF ( Lipson et al, 2003 ), and more recently, TiO 2 nanoparticles supported ionic liquids ( Bakhshali-Dehkordi et al, 2020 ), Sc(OTf) 3 ( Gajaganti et al, 2018 ) and DABCO-based ionic liquid supported on Fe 3 O 4 @TiO 2 nanoparticles ( Bakhshali‐Dehkordi et al, 2020 ). Despite the usefulness of these catalysts, they also have some limitations, including high toxicity, use of expensive materials, complex synthetic processes, requirement of expensive and hazardous catalysts, and sometimes low yields.…”